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Aim: Proinflammatory cytokine IL-1 [3 plays a critical role in carti- 
lage degeneration and elicits its catabolic response via enhanced 
production of reactive oxygen species (ROS) and nitric oxide (NO) 
in chondrocytes. Both ROS and NO induce apoptosis in chon- 
drocytes and cartilage degradation in arthritic joints. In this study, 
we used phenyI-N-tert-butylnitrone (PBN) which has shown 
potential pharmacological ctivities in various animal models of 
degenerative disorders involving free radicals such as aging and 
neurodegeneration, to inhibit I!_-1~-induced inflammatory stimuli 
in human chondrocytes. 
Methods: Safe dose regimen of PBN was determined by trypan 
blue exclusion assay and its effect on IL-l~-induced expression 
of iNOS and COX-2 and their reaction products, NO and PGE2, 
and apoptosis in human OA chondrocytes was determined by 
Western blotting and ELISA. To assess whether PBN can protect 
against oxidative damage we determined its effect on calcium 
ionophore A23187-induced lipid peroxidation and the expression 
of matrix metalloproteinases in human OA chondrocytes. 
Results: We show that PBN inhibited IL-l~-induced expres- 
sion of iNOS and COX-2 and their reaction products, NO and 
PGE2 respectively and also inhibited nitrosation of tymsine in 
human OA chondrocytes. Additionally, PBN inhibited IL-113- 
induced phosphorylation of c-jun N-terminal kinases/stress acti- 
vated protein kinase (JNK/SAPK) in human OA chondrocytes. 
Co-treatment with PBN also inhibited IL-113-induced apoptosis as 
evidenced by inhibition of PARP cleavage. In addition, our results 
showed that PBN significantly inhibited the calcium ionophore 
A23187-induced expression of matrix metalloproteinases and 
peroxidative damage to chondrocyte celt membranes. 
Conclusion: Our results indicate that PBN was non-toxic to 
human OA chondrocytes and inhibited 11_-1 ~-induced amage by 
inhibiting the activation of JNK/SAPK, matrix metalloproteinases 
and expression of iNOS and COX-2. This study suggests that 
PBN may be of value in the treatment of OA. 
This work was supported in part by National Institute Of Health 
grants AR-44902 and AR-206 18 (NEOMAC) and funds from the 
Department of Orthopaedics. 
